Analysts See $0.03 EPS for Inovalon Holdings, Inc. (INOV)

April 12, 2018 - By Ellis Scott

Inovalon Holdings, Inc. (NASDAQ:INOV) Logo

Analysts expect Inovalon Holdings, Inc. (NASDAQ:INOV) to report $0.03 EPS on May, 2.They anticipate $0.02 EPS change or 40.00 % from last quarter’s $0.05 EPS. INOV’s profit would be $4.33M giving it 86.88 P/E if the $0.03 EPS is correct. After having $0.04 EPS previously, Inovalon Holdings, Inc.’s analysts see -25.00 % EPS growth. The stock decreased 0.71% or $0.075 during the last trading session, reaching $10.425. About 146,896 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 14.88% since April 12, 2017 and is downtrending. It has underperformed by 26.43% the S&P500.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

Among 5 analysts covering Inovalon (NASDAQ:INOV), 0 have Buy rating, 2 Sell and 3 Hold. Therefore 0 are positive. Inovalon had 5 analyst reports since October 13, 2017 according to SRatingsIntel. The firm earned “Market Perform” rating on Wednesday, February 21 by Wells Fargo. The stock of Inovalon Holdings, Inc. (NASDAQ:INOV) has “Underweight” rating given on Wednesday, March 14 by Morgan Stanley. The rating was maintained by Robert W. Baird on Friday, October 13 with “Hold”. The stock of Inovalon Holdings, Inc. (NASDAQ:INOV) has “Sell” rating given on Wednesday, February 21 by Piper Jaffray. As per Monday, October 16, the company rating was maintained by KeyBanc Capital Markets.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.51 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It has a 43.8 P/E ratio. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: